Efficacy and Safety of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for Melanoma

NCT02211131 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma

Interventions

DRUG: Talimogene Laherparepvec
PROCEDURE: Immediate surgical resection of melanoma lesion(s)

Sponsor

Amgen